Agency Information Collection Activities; Proposed Collection; Comment Request, 9051-9054 [2013-02549]
Download as PDF
Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices
agree to submit to reasonable security
measures. The meeting space is
intended to accommodate public
attendees. However, if the space will not
accommodate all requests, the ASC may
refuse attendance on that reasonable
basis. The use of any video or audio
tape recording device, photographing
device, or any other electronic or
mechanical device designed for similar
purposes is prohibited at ASC meetings.
Dated: February 1, 2013.
James R. Park,
Executive Director.
[FR Doc. 2013–02732 Filed 2–6–13; 8:45 am]
BILLING CODE P
are found, the tariff of United Logistics
(LAX) Inc. should be suspended
pursuant to section 13 of the Shipping
Act, 46 U.S.C. 41108(a);
(5) whether the Ocean Transportation
Intermediary license of United Logistics
(LAX) Inc. should be suspended or
revoked pursuant to section 19 of the
Shipping Act, 46 U.S.C. 40903; and
(6) whether, in the event violations
are found, an appropriate cease and
desist order should be issued as
authorized by section 14 of the Shipping
Act, 46 U.S.C. 41304.
The Order may be viewed in its
entirety at https://www.fmc.gov/13-01.
Karen V. Gregory,
Secretary.
FEDERAL MARITIME COMMISSION
[FR Doc. 2013–02819 Filed 2–6–13; 8:45 am]
[Docket No. 13–01]
BILLING CODE 6730–01–P
Order of Investigation and Hearing:
United Logistics (Lax) Inc.—Possible
Violations of the Shipping Act of 1984
FEDERAL RESERVE SYSTEM
Federal Maritime Commission.
The Order of Investigation and
Hearing was served January 25, 2013.
ACTION: Notice of Order of Investigation
and Hearing.
AGENCY:
DATES:
Authority: 46 U.S.C. 41302.
On
January 25, 2013 the Federal Maritime
Commission instituted an Order of
Investigation and Hearing entitled
United Logistics (LAX) Inc.—Possible
Violations of Sections 10(a)(1) and
10(b)(2)(A) of the Shipping Act of 1984.
Acting pursuant to Section 11 of the
Shipping Act, 46 U.S.C. 41302, that
investigation is instituted to determine:
(1) Whether United Logistics (LAX)
Inc. violated section 10(a)(1) of the
Shipping Act, 46 U.S.C. 41102(a) by
knowingly and willfully, directly or
indirectly, obtaining transportation at
less than the rates and charges
otherwise applicable by the device or
means of unlawfully accessing service
contracts to which it was neither a
signatory nor an affiliate;
(2) whether United Logistics (LAX)
Inc. violated section 10(b)(2)(A) of the
Shipping Act, 46 U.S.C. 41104(2)(A), by
providing transportation in the liner
trade that was not in accordance with
the rates, charges, classifications, rules,
and practices contained in its published
tariff;
(3) whether, in the event violations of
section 10 of the Shipping Act are
found, civil penalties should be
assessed against United Logistics (LAX)
Inc. and, if so, the amount of the
penalties to be assessed;
(4) whether, in the event violations of
section 10(b)(2)(A) of the Shipping Act
mstockstill on DSK4VPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
17:45 Feb 06, 2013
Jkt 229001
Fmt 4703
Board of Governors of the Federal Reserve
System, February 4, 2013.
Margaret McCloskey Shanks,
Deputy Secretary of the Board.
[FR Doc. 2013–02767 Filed 2–6–13; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities; Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
The companies listed in this notice
have given notice under section 4 of the
Bank Holding Company Act (12 U.S.C.
1843) (BHC Act) and Regulation Y, (12
CFR part 225) to engage de novo, or to
acquire or control voting securities or
assets of a company, including the
companies listed below, that engages
either directly or through a subsidiary or
other company, in a nonbanking activity
that is listed in § 225.28 of Regulation Y
(12 CFR 225.28) or that the Board has
determined by Order to be closely
related to banking and permissible for
bank holding companies. Unless
otherwise noted, these activities will be
conducted throughout the United States.
Each notice is available for inspection
at the Federal Reserve Bank indicated.
The notice also will be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
question whether the proposal complies
with the standards of section 4 of the
BHC Act.
Unless otherwise noted, comments
regarding the applications must be
received at the Reserve Bank indicated
or the offices of the Board of Governors
not later than February 22, 2013.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. Baylake Corporation, Sturgeon Bay,
Wisconsin; to engage de novo through
its subsidiary, Admiral Asset
Management, LLC, Green Bay,
Wisconsin, in conducting registered
Frm 00025
investment advisory services, pursuant
to section 225.28(b)(6).
AGENCY:
Notice of Proposals To Engage in or
To Acquire Companies Engaged in
Permissible Nonbanking Activities
PO 00000
9051
Sfmt 4703
This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Improving Sickle Cell Transitions of
Care through Health Information
Technology Phase 1.’’ In accordance
with the Paperwork Reduction Act, 44
U.S.C. 3501–3521, AHRQ invites the
public to comment on this proposed
information collection.
DATES: Comments on this notice must be
received by April 8, 2013.
ADDRESSES: Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by
email at doris.lefkowitz,AHRQ.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
email at doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Proposed Project
Improving Sickle Cell Transitions of
Care Through Health Information
Technology Phase 1
This project is the first phase in
AHRQ’s effort toward the development
of a health information technology (HIT)
enabled tool designed to aid adolescents
and young adults with sickle cell
disease (SCD) during transitions of care.
SCD is a serious, genetic blood disorder
that affects approximately 70,000–
100,000 Americans, including one out
of every 500 African American and one
E:\FR\FM\07FEN1.SGM
07FEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
9052
Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices
out of every 36,000 Hispanic American
births. Persons with SCD produce
abnormal, ‘‘sickle-shaped’’ red blood
cells that obstruct blood vessels, leading
to life-long anemia, organ damage,
increased potential for infections,
chronic episodes of pain, and
substantially shortened life spans. SCD
has been noted to be understudied
relative to its prevalence resulting in a
lack of knowledge about the important
variables and domains that determine
health outcomes for patients.
Furthermore, patients with SCD,
typically young, minority, and often of
lower income status, have had few
opportunities to voice their needs and
concerns about their health and health
care.
As recently as 30 years ago, children
with SCD usually did not survive into
adulthood. Now, as a result of advances
in screening and treatment, more than
90 percent of individuals with SCD
reach adulthood, and life expectancy is
typically into the fifth decade. Persons
with SCD experience multiple
transitions of care as a result of the
chronicity of SCD, frequency of both
acute and chronic events requiring care,
as well as the advancements in life
expectancy. Transitions of care occur
when either the setting of care changes
(e.g., from home-based to hospital-based
care) or the focus of care changes (e.g.,
from pediatric-focused to adult-focused
care). When transitions of care occur, a
need to share medical history and other
types of health information arises.
Transitions of care are more likely to be
successful when this health information
is accurate, tailored to the type of
transition taking place, and
communicated effectively.
Times of care transitions are
particularly fraught for patients with
SCD and currently, few patients have
access to effective transition programs
for SCD. In a 2010 survey of pediatric
SCD providers, the majority claimed to
have transition programs in place but
they were often newly formed and
without the ability to transfer care to
adult providers with specific expertise
in SCD.
Preliminary evidence suggests that
HIT can be helpful for SCD and similar
conditions. In particular, a technologybased tool has already been used
successfully by patients with SCD to
help with some aspects of disease
management. In one study, a handheld
wireless device was used to implement
a pain management protocol and found
to result in high rates of participation
and satisfaction. Technology-based tools
or applications—‘‘apps’’—have also
been effective in improving care
transitions for other chronic diseases
VerDate Mar<15>2010
17:45 Feb 06, 2013
Jkt 229001
such as diabetes and HIV, which can
serve as models for this tool.
Improving transitions of care is the
focus of AHRQ’s plans to respond to the
Department of Health and Human
Services’ (HHS’) SCD Initiative
announced in 2011. The overall HHS
SCD initiative, which is aligned with
AHRQ’s mission, aims to improve the
health of persons with SCD through
various activities, including developing
and disseminating evidence-based
guidelines, increasing the availability of
medical homes that provide SCD care,
and supporting research in areas such as
pain and disease management, all of
which could also be supported through
the use of an effective HIT enabled tool.
The goals of this project are to:
(1) Gain the necessary background
knowledge including qualitative
information from key stakeholders, to
establish a set of requirements that
would guide the design and
development of a HIT-enabled tool in
future phases of work that meets
patients,’ families,’ and providers’ needs
to aid adolescents and young adults
with sickle cell disease during
transitions of care.
(2) Develop an understanding of the
environmental context, current
facilitators and barriers, health data use
and needs of key stakeholders affected
by sickle cell disease, including
patients, families, and providers.
This study is being conducted by
AHRQ through its contractor, The
Lewin Group, pursuant to AHRQ’s
authority to conduct and support
research on healthcare and on systems
for the delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of healthcare
services and health care technologies.
42 U.S.C. 299a(a)(1), (2) and (5).
Method of Collection
To achieve the goals of this project,
the following activities and data
collections will be implemented:
(1) Environmental Scan — AHRQ will
execute a literature review to identify
potentially relevant scientific literature
and information from other literature
and sources as well as complete a search
for existing tools that aid transitions of
care for persons with SCD or similar
conditions. This will provide contextual
background about the current state of
the field with regards to tool
development and use, identify key
issues of patients with SCD related to
care transitions, and understand the
context of care delivered and health
data information needs to inform the
content, design and functionality of a
tool. This activity does not impose a
PO 00000
Frm 00026
Fmt 4703
Sfmt 4703
burden on the public and is not
included in the burden estimates in
Exhibit 1.
(2) Focus Groups — AHRQ will
facilitate ten focus groups of key
stakeholder groups including: parents/
caregivers of patients with SCD; health
care providers (e.g. SCD specialists,
primary care physicians (PCPs),
hospitalists and emergency room (ER)
physicians); IT developers; SCD patients
ages 9–13; SCD patients ages 14–17;
SCD patients 18 and older; and SCD
patients of mixed ages; to gather
qualitative information on stakeholder
experiences with SCD and care
transitions, barriers to quality care, and
use of technology to inform tool design
and functionality. Each group will
consist of 10 participants and will be
asked to describe their particular
experiences with health care transitions,
communication practices, information
needs and technology use in order to
develop relevant ‘‘use cases’’ which will
be used by investigators and tool
developers for the later phases of the
project. The in-person nature of focus
groups allows for a more in-depth and
targeted discussion, including
participant experiences, impressions
and priorities in a detailed fashion.
(3) Demographic Questionnaire —
AHRQ will implement a short
demographic questionnaire at the start
of each of the ten focus groups to collect
basic demographic information to allow
the team to contextualize findings from
each focus group. Questionnaires are
tailored to each focus group category:
parents/caregivers of patients with SCD;
providers, hospitalists and ER
physicians); IT developers; SCD patients
ages 9–13; SCD patients ages 14–17;
SCD patients 18 and older; and SCD
patients of mixed ages.
(4) Key Informant Interviews — AHRQ
will conduct eight key informant
interviews with stakeholders such as
State Medicaid representatives,
attorneys with expertise in privacy and
security issues, representatives from the
Office of the National Coordinator for
Health Information Technology (ONC),
Office of Chief Scientist, and other
relevant policy makers. Qualitative
information gained will contribute to
tool development recommendations
particularly in terms of cost, issues
related to reimbursement by payers,
needs for proof of effectiveness,
sustainability, and potential vehicles for
facilitating and funding tool
development and implementation. Five
of these stakeholders will be Federal
government employees and therefore are
excluded from the burden estimates in
Exhibit 1 below.
E:\FR\FM\07FEN1.SGM
07FEN1
9053
Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices
The information gained from the
focus groups and key informant
interviews will be used to understand if
and how a patient-centered, HITenabled tool can improve the health of
individuals with SCD during care
transitions.
Focus groups as a form of qualitative
research are an important vehicle for
gathering and explicating insight from
the field, especially if, as in this case,
the important domains are not yet
understood, and need to be outlined by
respondents, rather than suggested by
investigators. Thus active recruitment
and qualitative techniques are a means
to incorporate this necessary and
important perspective into the
derivation of effective interventions.
The primary objective of the focus
groups is to gather more richly nuanced
information from sickle cell disease
stakeholders. The in-person nature of
focus groups allows for a more in-depth
and targeted discussion, including
participant experiences, impressions
and priorities in a detailed fashion.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated
annualized burden hours for the
respondents’ time to participate in this
research. The demographic
questionnaire will be completed by each
focus group participant and takes 6
minutes to complete. All of the focus
groups and key informant interviews
will last 2 hours except for the IT
developer focus group which will last 4
hours. Each focus group will consist of
10 persons. There will be two focus
groups with providers, three with
parents/caregivers, one group for IT
developers, and one focus group with
each of the four patient groups. Key
informant interviews will be conducted
with eight individuals. The total burden
is estimated to be 236 hours annually.
Exhibit 2 shows the estimated
annualized cost burden associated with
the respondents’ time to participate in
this research. The total cost burden is
estimated to be $7,646 annually.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of
responses
per
respondent
Hours per
response
Total burden
hours
Demographic Questionnaire ............................................................................
Provider Focus Groups ....................................................................................
Parent/Caregiver Focus Groups ......................................................................
IT Developer Focus Group ..............................................................................
Patients 9–13 Focus Group .............................................................................
Patients 14–17 Focus Group ...........................................................................
Patients 18 & older Focus Group ....................................................................
Patients mixed ages Focus Group ..................................................................
Key Informant Interviews .................................................................................
100
20
30
10
10
10
10
10
3
1
1
1
1
1
1
1
1
1
6/60
2
2
4
2
2
2
2
2
10
40
60
40
20
20
20
20
6
Total ..........................................................................................................
203
na
na
236
* Five interview participants will be Federal government employees and therefore are excluded from the burden estimates.
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of
respondents
Form name
Total burden
hours
Average
hourly wage
rate *
Total
cost burden
Demographic Questionnaire ............................................................................
Provider Focus Groups ....................................................................................
Parent/Caregiver Focus Groups ......................................................................
IT Developer Focus Group ..............................................................................
Patients 9–13 Focus Group .............................................................................
Patients 14–17 Focus Group ...........................................................................
Patients 18 & older Focus Group ....................................................................
Patients mixed ages Focus Group ..................................................................
Key Informant Interviews .................................................................................
100
20
30
10
10
10
10
10
3
10
40
60
40
20
20
20
20
6
a $26.89
f 52.72
$269
3,551
1,304
1,771
0
0
435
0
316
Total ..........................................................................................................
203
236
na
7,646
b 88.7
a 21.74
d 44.27
e0
e0
a 21.74
e0
mstockstill on DSK4VPTVN1PROD with NOTICES
a Based
on the mean wages for Physicians & Surgeons, All other (29–1069), All Occupations (00–0000), Software Developer (15–1132).
Wages for children averaged in as $0.
b Based on the mean wages for Physicians & Surgeons, All other (29–1069).
c Based on the mean wages for All Occupations (00–0000).
d Based on the mean wages for Software Developer (15–1132).
e No wage data for children.
f Based on the mean wages for Lawyers (23–1011), Social and Community Service Managers (11–9151), Medical and Health Services Managers (11–9111), and Computer and Information System Managers (11–3021).
* National Compensation Survey: Occupational wages in the United States May 2011, ‘‘U.S. Department of Labor, Bureau of Labor Statistics.’’
https://www.bls.gov/oes/current/oes_nat.htm#15-0000.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
VerDate Mar<15>2010
18:18 Feb 06, 2013
Jkt 229001
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ health care
research and health care information
dissemination functions, including
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
E:\FR\FM\07FEN1.SGM
07FEN1
9054
Federal Register / Vol. 78, No. 26 / Thursday, February 7, 2013 / Notices
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: January 23, 2013.
Carolyn M. Clancy,
Director.
[FR Doc. 2013–02549 Filed 2–6–13; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–144]
Issuance of Final Guidance Publication
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
Notice of issuance of final
guidance publication.
ACTION:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
announces the availability of the
following publication: ‘‘NIOSH Criteria
for a Recommended Standard:
Occupational Exposure to Hexavalent
Chromium’’ [2013–128].
SUMMARY:
This document may be
obtained at the following link: Web site:
https://www.cdc.gov/niosh/docs/2013128/.
ADDRESSES:
mstockstill on DSK4VPTVN1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
Kathleen MacMahon, NIOSH, Robert A.
Taft Laboratories, MS–C14, 4676
Columbia Parkway, Cincinnati, OH
45226, telephone (513) 533–8547.
Dated: January 28, 2013.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
BILLING CODE 4163–18–P
VerDate Mar<15>2010
17:45 Feb 06, 2013
Jkt 229001
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health Respiratory
Protection for Healthcare Workers:
Stakeholder Meeting
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of public meeting.
AGENCY:
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the following public
meeting: ‘‘Stakeholder Meeting on
Respiratory Protection for Healthcare
Workers’’.
Stakeholder Meeting Time and Date:
8 a.m.–5:15 p.m. EDT, June 18, 2013.
Place: CDC Tom Harkin Global
Communications Center located at 1600
Clifton Road, Building 19, Atlanta,
Georgia 30333. This meeting will also be
available by videoconference at select
CDC locations.
Purpose of the Meeting: This meeting
is being held to exchange ideas and
solutions to improve healthcare worker
compliance with personal protective
technologies (PPT), with a focus on
respiratory protection. Stakeholder
feedback is sought to (1) provide input
to future updates of the NIOSH PPT
program research agenda and (2) assess
progress toward better respirators for
healthcare workers.
This meeting will include
presentations and moderated roundtable
discussions on ‘‘Improving the Evidence
Base to Support Guidance on the
Appropriate Level of Respiratory
Protection’’, ‘‘Healthcare Worker
Observational Studies of Respirator Use
& New Educational Resources’’,
‘‘Considerations for Extending
Respirator Supplies During an Outbreak
or Pandemic’’, ‘‘Standards & Test
Methods for Improved Respirators for
Healthcare Workers’’, and ‘‘Advances
toward Improved Respirators for
Healthcare Workers’’.
Status: The meeting is open to the
public, limited only by the capacity
(100) of the conference room.
Registration will be accepted on a first
come first served basis. Participants are
encouraged to consider attending by
video conference, which will be
provided at select CDC locations (to be
SUMMARY:
BILLING CODE 4160–90–M
[FR Doc. 2013–02743 Filed 2–6–13; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
announced). Registration for both in
person and video conference attendance
is available on the NIOSH NPPTL Web
site, www.cdc.gov/niosh/npptl.
Preregistration is required on or before
May 31, 2013, even for remote attendees
and US citizens. Non-US citizens need
to register on or before May 18, 2013, to
allow sufficient time for mandatory CDC
facility security clearance procedures to
be completed. An email confirming
registration will be sent from NIOSH
and will include details needed to
participate. A government issued photo
ID will be required to obtain entrance to
any of the CDC locations.
Background: The NIOSH PPT
program publishes and periodically
updates its research agenda on personal
protective equipment (PPE) for
healthcare workers (https://
www.cdc.gov/niosh/docket/archive/
docket129.html). The research agenda,
last updated in 2010, describes the near
term and long term strategy for the PPT
program’s influenza pandemic research,
development, and investigative testing
activities. Recently, the Institute of
Medicine (IOM) published a report
(https://www.iom.edu/Reports/2011/
Preventing-Transmission-of-PandemicInfluenza-and-Other-Viral-RespiratoryDiseases.aspx) that assessed the nation’s
progress on improving PPE for
healthcare personnel exposed to
infectious respiratory diseases and made
recommendations to address research
gaps. Furthermore, a chapter in the
recent HHS 2009 H1N1 Influenza
Improvement Plan (https://www.phe.gov/
Preparedness/mcm/h1n1-retrospective/
Documents/2009-h1n1improvementplan.pdf) discusses
research needs for respiratory protective
devices as part of a broader non-vaccine
medical countermeasures strategy. A
key area of discussion at this
stakeholder meeting will be progress on
research gaps identified in the 2011
IOM and 2012 HHS reports and how
NIOSH can use this information to
update the 2010 PPT research agenda.
The current version of PPT program
research agenda for healthcare worker
PPE focuses on conducting research to
design and promote the appropriate use
of PPE. Compliance with appropriate
respirator use practices is important
because healthcare workers often wear
them incorrectly or fail to use them at
all. Poor compliance has been linked to
safety culture, workload issues, time
constraints, risk perception,
effectiveness concerns, availability,
discomfort, interference with patient
care, and communication difficulties.
One strategy taken to improve
healthcare worker compliance is to
develop better respirators. In this
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 78, Number 26 (Thursday, February 7, 2013)]
[Notices]
[Pages 9051-9054]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-02549]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities; Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Improving Sickle Cell Transitions of Care through Health
Information Technology Phase 1.'' In accordance with the Paperwork
Reduction Act, 44 U.S.C. 3501-3521, AHRQ invites the public to comment
on this proposed information collection.
DATES: Comments on this notice must be received by April 8, 2013.
ADDRESSES: Written comments should be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by email at
doris.lefkowitz,AHRQ.hhs.gov.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by email at
AHRQ.hhs.gov">doris.lefkowitz@AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
Improving Sickle Cell Transitions of Care Through Health Information
Technology Phase 1
This project is the first phase in AHRQ's effort toward the
development of a health information technology (HIT) enabled tool
designed to aid adolescents and young adults with sickle cell disease
(SCD) during transitions of care. SCD is a serious, genetic blood
disorder that affects approximately 70,000-100,000 Americans, including
one out of every 500 African American and one
[[Page 9052]]
out of every 36,000 Hispanic American births. Persons with SCD produce
abnormal, ``sickle-shaped'' red blood cells that obstruct blood
vessels, leading to life-long anemia, organ damage, increased potential
for infections, chronic episodes of pain, and substantially shortened
life spans. SCD has been noted to be understudied relative to its
prevalence resulting in a lack of knowledge about the important
variables and domains that determine health outcomes for patients.
Furthermore, patients with SCD, typically young, minority, and often of
lower income status, have had few opportunities to voice their needs
and concerns about their health and health care.
As recently as 30 years ago, children with SCD usually did not
survive into adulthood. Now, as a result of advances in screening and
treatment, more than 90 percent of individuals with SCD reach
adulthood, and life expectancy is typically into the fifth decade.
Persons with SCD experience multiple transitions of care as a result of
the chronicity of SCD, frequency of both acute and chronic events
requiring care, as well as the advancements in life expectancy.
Transitions of care occur when either the setting of care changes
(e.g., from home-based to hospital-based care) or the focus of care
changes (e.g., from pediatric-focused to adult-focused care). When
transitions of care occur, a need to share medical history and other
types of health information arises. Transitions of care are more likely
to be successful when this health information is accurate, tailored to
the type of transition taking place, and communicated effectively.
Times of care transitions are particularly fraught for patients
with SCD and currently, few patients have access to effective
transition programs for SCD. In a 2010 survey of pediatric SCD
providers, the majority claimed to have transition programs in place
but they were often newly formed and without the ability to transfer
care to adult providers with specific expertise in SCD.
Preliminary evidence suggests that HIT can be helpful for SCD and
similar conditions. In particular, a technology-based tool has already
been used successfully by patients with SCD to help with some aspects
of disease management. In one study, a handheld wireless device was
used to implement a pain management protocol and found to result in
high rates of participation and satisfaction. Technology-based tools or
applications--``apps''--have also been effective in improving care
transitions for other chronic diseases such as diabetes and HIV, which
can serve as models for this tool.
Improving transitions of care is the focus of AHRQ's plans to
respond to the Department of Health and Human Services' (HHS') SCD
Initiative announced in 2011. The overall HHS SCD initiative, which is
aligned with AHRQ's mission, aims to improve the health of persons with
SCD through various activities, including developing and disseminating
evidence-based guidelines, increasing the availability of medical homes
that provide SCD care, and supporting research in areas such as pain
and disease management, all of which could also be supported through
the use of an effective HIT enabled tool.
The goals of this project are to:
(1) Gain the necessary background knowledge including qualitative
information from key stakeholders, to establish a set of requirements
that would guide the design and development of a HIT-enabled tool in
future phases of work that meets patients,' families,' and providers'
needs to aid adolescents and young adults with sickle cell disease
during transitions of care.
(2) Develop an understanding of the environmental context, current
facilitators and barriers, health data use and needs of key
stakeholders affected by sickle cell disease, including patients,
families, and providers.
This study is being conducted by AHRQ through its contractor, The
Lewin Group, pursuant to AHRQ's authority to conduct and support
research on healthcare and on systems for the delivery of such care,
including activities with respect to the quality, effectiveness,
efficiency, appropriateness and value of healthcare services and health
care technologies. 42 U.S.C. 299a(a)(1), (2) and (5).
Method of Collection
To achieve the goals of this project, the following activities and
data collections will be implemented:
(1) Environmental Scan -- AHRQ will execute a literature review to
identify potentially relevant scientific literature and information
from other literature and sources as well as complete a search for
existing tools that aid transitions of care for persons with SCD or
similar conditions. This will provide contextual background about the
current state of the field with regards to tool development and use,
identify key issues of patients with SCD related to care transitions,
and understand the context of care delivered and health data
information needs to inform the content, design and functionality of a
tool. This activity does not impose a burden on the public and is not
included in the burden estimates in Exhibit 1.
(2) Focus Groups -- AHRQ will facilitate ten focus groups of key
stakeholder groups including: parents/caregivers of patients with SCD;
health care providers (e.g. SCD specialists, primary care physicians
(PCPs), hospitalists and emergency room (ER) physicians); IT
developers; SCD patients ages 9-13; SCD patients ages 14-17; SCD
patients 18 and older; and SCD patients of mixed ages; to gather
qualitative information on stakeholder experiences with SCD and care
transitions, barriers to quality care, and use of technology to inform
tool design and functionality. Each group will consist of 10
participants and will be asked to describe their particular experiences
with health care transitions, communication practices, information
needs and technology use in order to develop relevant ``use cases''
which will be used by investigators and tool developers for the later
phases of the project. The in-person nature of focus groups allows for
a more in-depth and targeted discussion, including participant
experiences, impressions and priorities in a detailed fashion.
(3) Demographic Questionnaire -- AHRQ will implement a short
demographic questionnaire at the start of each of the ten focus groups
to collect basic demographic information to allow the team to
contextualize findings from each focus group. Questionnaires are
tailored to each focus group category: parents/caregivers of patients
with SCD; providers, hospitalists and ER physicians); IT developers;
SCD patients ages 9-13; SCD patients ages 14-17; SCD patients 18 and
older; and SCD patients of mixed ages.
(4) Key Informant Interviews -- AHRQ will conduct eight key
informant interviews with stakeholders such as State Medicaid
representatives, attorneys with expertise in privacy and security
issues, representatives from the Office of the National Coordinator for
Health Information Technology (ONC), Office of Chief Scientist, and
other relevant policy makers. Qualitative information gained will
contribute to tool development recommendations particularly in terms of
cost, issues related to reimbursement by payers, needs for proof of
effectiveness, sustainability, and potential vehicles for facilitating
and funding tool development and implementation. Five of these
stakeholders will be Federal government employees and therefore are
excluded from the burden estimates in Exhibit 1 below.
[[Page 9053]]
The information gained from the focus groups and key informant
interviews will be used to understand if and how a patient-centered,
HIT-enabled tool can improve the health of individuals with SCD during
care transitions.
Focus groups as a form of qualitative research are an important
vehicle for gathering and explicating insight from the field,
especially if, as in this case, the important domains are not yet
understood, and need to be outlined by respondents, rather than
suggested by investigators. Thus active recruitment and qualitative
techniques are a means to incorporate this necessary and important
perspective into the derivation of effective interventions. The primary
objective of the focus groups is to gather more richly nuanced
information from sickle cell disease stakeholders. The in-person nature
of focus groups allows for a more in-depth and targeted discussion,
including participant experiences, impressions and priorities in a
detailed fashion.
Estimated Annual Respondent Burden
Exhibit 1 shows the estimated annualized burden hours for the
respondents' time to participate in this research. The demographic
questionnaire will be completed by each focus group participant and
takes 6 minutes to complete. All of the focus groups and key informant
interviews will last 2 hours except for the IT developer focus group
which will last 4 hours. Each focus group will consist of 10 persons.
There will be two focus groups with providers, three with parents/
caregivers, one group for IT developers, and one focus group with each
of the four patient groups. Key informant interviews will be conducted
with eight individuals. The total burden is estimated to be 236 hours
annually.
Exhibit 2 shows the estimated annualized cost burden associated
with the respondents' time to participate in this research. The total
cost burden is estimated to be $7,646 annually.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Demographic Questionnaire....................... 100 1 6/60 10
Provider Focus Groups........................... 20 1 2 40
Parent/Caregiver Focus Groups................... 30 1 2 60
IT Developer Focus Group........................ 10 1 4 40
Patients 9-13 Focus Group....................... 10 1 2 20
Patients 14-17 Focus Group...................... 10 1 2 20
Patients 18 & older Focus Group................. 10 1 2 20
Patients mixed ages Focus Group................. 10 1 2 20
Key Informant Interviews........................ 3 1 2 6
---------------------------------------------------------------
Total....................................... 203 na na 236
----------------------------------------------------------------------------------------------------------------
* Five interview participants will be Federal government employees and therefore are excluded from the burden
estimates.
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Form name respondents hours wage rate * burden
----------------------------------------------------------------------------------------------------------------
Demographic Questionnaire....................... 100 10 \a\ $26.89 $269
Provider Focus Groups........................... 20 40 \b\ 88.7 3,551
Parent/Caregiver Focus Groups................... 30 60 \a\ 21.74 1,304
IT Developer Focus Group........................ 10 40 \d\ 44.27 1,771
Patients 9-13 Focus Group....................... 10 20 \e\ 0 0
Patients 14-17 Focus Group...................... 10 20 \e\ 0 0
Patients 18 & older Focus Group................. 10 20 \a\ 21.74 435
Patients mixed ages Focus Group................. 10 20 \e\ 0 0
Key Informant Interviews........................ 3 6 \f\ 52.72 316
---------------------------------------------------------------
Total....................................... 203 236 na 7,646
----------------------------------------------------------------------------------------------------------------
\a\ Based on the mean wages for Physicians & Surgeons, All other (29-1069), All Occupations (00-0000), Software
Developer (15-1132). Wages for children averaged in as $0.
\b\ Based on the mean wages for Physicians & Surgeons, All other (29-1069).
\c\ Based on the mean wages for All Occupations (00-0000).
\d\ Based on the mean wages for Software Developer (15-1132).
\e\ No wage data for children.
\f\ Based on the mean wages for Lawyers (23-1011), Social and Community Service Managers (11-9151), Medical and
Health Services Managers (11-9111), and Computer and Information System Managers (11-3021).
* National Compensation Survey: Occupational wages in the United States May 2011, ``U.S. Department of Labor,
Bureau of Labor Statistics.'' https://www.bls.gov/oes/current/oes_nat.htm#15-0000.
Request for Comments
In accordance with the Paperwork Reduction Act, comments on AHRQ's
information collection are requested with regard to any of the
following: (a) Whether the proposed collection of information is
necessary for the proper performance of AHRQ health care research and
health care information dissemination functions, including whether the
information will have practical utility; (b) the accuracy of AHRQ's
estimate of burden (including hours and costs) of the proposed
collection(s) of information; (c) ways to
[[Page 9054]]
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information upon the respondents, including the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: January 23, 2013.
Carolyn M. Clancy,
Director.
[FR Doc. 2013-02549 Filed 2-6-13; 8:45 am]
BILLING CODE 4160-90-M